Coinme Resumes Full Operations in Washington State

Coinme Reaches Agreement with Washington Department of Financial Institutions to Stay Temporary Order to Cease and Desist Coinme, Inc., Washington State's first licensed cryptocurrency exchange, today announced that it has reached an agreement with the Washington State Department of Financial Institutions (WA DFI) to stay the agency's temporary order to cease and desist, allowing the […]

Magaya Celebrates a Remarkable Year of Growth, Innovation, and Industry Leadership in 2025

Magaya Corporation, the leading freight management platform for logistics service providers, today announced the close of a standout year marked by strong performance, meaningful innovation, and deepened engagement with freight forwarders and customs brokers worldwide. Despite ongoing uncertainty across global trade and regulatory environments, Magaya exceeded growth goals in 2025, continued to invest in product

IM Cannabis Explores U.S. Market Entry Following President Trump’s Executive Order on Increasing Medical Marijuana and Cannabidiol Research

Engages Exclusive Financial Advisors for U.S. Opportunities and Potential Divestitures of German and Israeli Operations IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, today announced that it is actively evaluating certain strategic opportunities to expand its operations into the United States cannabis market. This initiative

AEON Brings Scan-to-Pay Crypto Payments to X Layer, Expanding Real-World Adoption Across Emerging Markets

AEON, the foundational payment and settlement layer built for the new AI economy, today announced a strategic integration with X Layer, the high-performanceEthereum Layer 2 network developed by OKX. This collaboration brings AEON's scan-to-pay capability directly to X Layer, enabling seamless real-world crypto payments across Southeast Asia, Africa, and Latin America. Through this integration, users

Shareholders who lost money in shares Coupang, Inc. (NYSE: CPNG) Should Contact Wolf Haldenstein Immediately

(NYSE:CPNG), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers Coupang, Inc. (NYSE: CPNG) (“Coupang”) that a federal securities class action has been filed on behalf of investors who purchased Coupang between August 6, 2025 and December 16, 2025, inclusive (the “Class Period”). Investors have

Shareholders who lost money in shares Coupang, Inc. (NYSE: CPNG) Should Contact Wolf Haldenstein Immediately

Shareholders who lost money in shares Coupang, Inc. (NYSE: CPNG) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is February 17, 2026 GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers Coupang, Inc. (NYSE: CPNG) (“Coupang”) that a federal securities class

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

(NASDAQ:IFRX), While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), subsequent post-hoc analyses suggest a positive trend in favor of vilobelimab, with signals indicating a potentially consistent treatment effect InflaRx anticipates meeting with the FDA to

ZenaTech Completes Three Acquisitions Accelerating North American Drone-as-a-Service Expansion and Service Capabilities

(NASDAQ:ZENA),(Boerse Frankfurt – Freiverkehr:49Q),(BMV:ZENA), VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces the completion of three strategic Drone as a Service acquisitions, two in

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

(NasdaqGM:XOMA),(NasdaqGM:XOMAO),(NasdaqGM:XOMAP), – Takeda regains a majority of XOMA Royalty's royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine development-stage assets held within Takeda's externalized assets portfolio – EMERYVILLE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA),

Scroll to Top